Omnicell Investor Presentation Deck
© 2023 Omnicell, Inc.
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Reconciliation of GAAP income from operations to non-GAAP income from operations:
GAAP income from operations
GAAP operating income % to total revenues
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
Severance-related expenses
Non-GAAP income from operations
Non-GAAP operating margin (non-GAAP operating income as a % of total non-GAAP revenues)
Reconciliation of GAAP net income to non-GAAP net income:
GAAP net income
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
(a)
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
S
$
$
Three Months Ended June 30,
2023
2022
$
2.6%
10.6%
7,748 $
14,089
8,035
246
841
721
31,680
3,451 $
14,089
8,035
246
$
841
721
1,046
(2,287)
26,142
3.8%
$
12,485
17,213
8,845
302
263
13.2%
3,340
1,374
43,822
Severance-related expenses
Amortization of debt issuance costs
(a)
Tax effect of the adjustments above
Non-GAAP net income
Tax effects calculated for all adjustments except share-based compensation expense, using an estimated annual effective tax rate of 21% for both fiscal years 2023 and 2022.
9,069
17,213
8,845
302
263
3,340
1,374
1,041
(3,185)
38,262
23View entire presentation